ESPR filings
Corporate insider profile
Benjamin Halladay Filing Activity
Latest reported as Chief Financial Officer of Esperion Therapeutics, Inc. (ESPR).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$33,988.82
- Latest transaction
- Jun 17, 2026
Affiliated corporations
Reported company relationships
Transaction history
